Skip to content

Exploring how to commercialise medical technology

At a recent Medical Technology Workshop, experts shared their perspectives on the challenges of bringing ideas to commercial and clinical fruition - exploring all aspects of medical technology development and commercialisation.

Experts from government, industry, health and education sectors spoke about the development, clinical validation and funding models needed to bring medical technologies to the clinic in order to improve health across the community.

Deputy Principal of the UNSW Medicine Cancer Theme and workshop convenor, A/Prof Phoebe Phillips explained,

“The best chance for commercialisation of your medical technology is starting with a clinical problem, strategically select the best interdisciplinary team, have an intellectual property plan, ensure there is a market for your technology and integrate a regulatory approval strategy throughout pipeline,” she said.

“I was motivated by the willingness of the MedTech industry and entrepreneurs to share their expertise and advice freely with academics.  I look forward to building these relationships to support academics and increase partnerships with industry to foster translation.”

Read the workshop program or watch the four workshop sessions for more tips:

·      SESSION 1: Project Development to Proof of Concept

·      SESSION 2: Product Development, Clinical Validation, and Market Entry

·      SESSION 3: Partnerships and Funding

·      SESSION 4: Case Studies

The workshop was sponsored by UNSW Medicine and two clinical academic groups (CAGs) from the Maridulu Budyari Gumal (SPHERE) network, the Triple I CAG and Cancer CAG. It was facilitated by Professor Joanne Tipper (co-director of Frontiers Technology CAG) from UTS.

Announcement of the Executive Director for Maridulu Budyari Gumal - SPHERE

I am delighted to announce that Professor Mark Parsons has been appointed as the Executive Director, Maridulu Budyari Gumal - Sydney Partnership for Health Education, Research and Enterprise (SPHERE).  He commenced in the role on 1 July 2021.

Funding success for the Maridulu Budyari Gumal - SPHERE Cancer Clinical Academic Group

The NSW Government through the Cancer Institute NSW has awarded SPHERE's Professor Geoff Delaney a $7M Translational Cancer Research Capacity Building Grant to build capacity and education across the SPHERE Cancer Clinical Academic Group. Commencing on 1 July, the 5 year program will enhance the volume of cancer research the CAG produces, but also to accelerate research translation; ensure succession planning by enhancing career development opportunities; and continue to stimulate high-quality, multidisciplinary, multi-institutional, innovative, impactful research.

Female Health Researchers Receive Financial Support to Advance Careers

Female researchers from across Australia working in women’s health research and translation have been provided financial support in a bid to facilitate the career advancement and development of women in early and mid-career stages of their research careers.